Sunto-gun, Japan

Chikako Katagiri

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chikako Katagiri: Innovator in Pancreatitis Treatment

Introduction

Chikako Katagiri is a notable inventor based in Sunto-gun, Japan. She has made significant contributions to the field of medicine, particularly in the development of treatments for pancreatitis. Her innovative approach has led to the creation of a unique therapeutic agent that addresses this challenging condition.

Latest Patents

Chikako Katagiri holds a patent for a pancreatitis remedy. The invention relates to a prophylactic agent or a therapeutic agent for pancreatitis, which contains an adenosine uptake inhibitor or a pharmaceutically acceptable salt thereof. This patent represents a significant advancement in the treatment options available for patients suffering from pancreatitis.

Career Highlights

Chikako Katagiri is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its commitment to pharmaceutical innovation. Her work at the company has been instrumental in advancing research and development in the field of therapeutic agents.

Collaborations

Chikako has collaborated with notable colleagues, including Yuko Okamura and Junichi Shimada. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Chikako Katagiri's contributions to the field of medicine, particularly through her patent for a pancreatitis remedy, highlight her role as an influential inventor. Her work continues to pave the way for new treatment options and demonstrates the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…